M, S., S, S., C, V., G, S., T, v. K., M, S., . . . T, K. (2019). Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatric blood & cancer, 66(6), e27652. https://doi.org/10.1002/pbc.27652
Chicago Style (17th ed.) CitationM, Sparber-Sauer, et al. "Rhabdomyosarcoma diagnosed in the First Year of Life: Localized, Metastatic, and Relapsed Disease. Outcome Data from Five Trials and One Registry of the Cooperative Weichteilsarkom Studiengruppe (CWS)." Pediatric Blood & Cancer 66, no. 6 (2019): e27652. https://doi.org/10.1002/pbc.27652.
MLA (9th ed.) CitationM, Sparber-Sauer, et al. "Rhabdomyosarcoma diagnosed in the First Year of Life: Localized, Metastatic, and Relapsed Disease. Outcome Data from Five Trials and One Registry of the Cooperative Weichteilsarkom Studiengruppe (CWS)." Pediatric Blood & Cancer, vol. 66, no. 6, 2019, p. e27652, https://doi.org/10.1002/pbc.27652.